Hikma CEO Speaks at Harvard School of Public Health’s MENA Conference

On November 18th 2010, Mr Said Darwazah, CEO of Hikma Pharmaceuticals, attended the Third Annual Harvard School of Public Health (“HSPH”) MENA Conference as the keynote speaker. The conference is a major event during the annual Harvard MENA Weekend attended by a select group of individuals including government officials, graduate students, industry leaders and alumni from Harvard, MIT, Stanford, Wharton, and Columbia. Events took place in November across Harvard’s different schools throughout the weekend. Hikma’s CEO, along with other representatives from top businesses in the MENA region, highlighted changes in the region and important elements to consider for the future.

Press Release Responsibility 10 December 2010

Mr Darwazah’s keynote address, in line with the conference theme of “Leading into the Future”, covered a range of topics affecting healthcare in the MENA region including the rapid population growth, increased life expectancy, increased incidence of chronic disease, and the wide spectrum of diseases prevalent in the region. Hikma’s distinguished CEO shared his knowledge of affordability and accessibility of healthcare in the Middle East and insights about the pharmaceutical market in the MENA region where Hikma is a leading producer of branded, injectable, and generic pharmaceutical products.
“I am honored to be asked to speak at Harvard’s MENA Weekend” stated Mr Said Darwazah. “This conference is an excellent opportunity to highlight the importance of healthcare in the region and to show Hikma’s support for education and awareness initiatives that focus on improving healthcare in the future.”

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.